» Articles » PMID: 22015170

Synthesis, Separation, and Characterization of Amphiphilic Sulfated Oligosaccharides Enabled by Reversed-phase Ion Pairing LC and LC-MS Methods

Overview
Journal Carbohydr Res
Publisher Elsevier
Date 2011 Oct 22
PMID 22015170
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Synthesis of amphiphilic oligosaccharides is problematic because traditional methods for separating and purifying oligosaccharides, including sulfated oligosaccharides, are generally not applicable to working with amphiphilic sugars. We report here RPIP-LC and LC-MS methods that enable the synthesis, separation, and characterization of amphiphilic N-arylacyl O-sulfonated aminoglycosides, which are being pursued as small-molecule glycosaminoglycan mimics. The methods described in this work for separating and characterizing these amphiphilic saccharides are further applied to a number of uses: monitoring the progression of sulfonation reactions with analytical RP-HPLC, characterizing sulfate content for individual molecules with ESI-MS, determining the degree of sulfation for products having mixed degrees of sulfation with HPLC and LC-MS, and purifying products with benchtop C18 column chromatography. We believe that the methods described here will be broadly applicable to enabling the synthesis, separation, and characterization of amphiphilic, sulfated, and phosphorylated oligosaccharides and other types of molecules substituted to varying degrees with both anionic and hydrophobic groups.

Citing Articles

Ultra-high-performance liquid chromatography charge transfer dissociation mass spectrometry (UHPLC-CTD-MS) as a tool for analyzing the structural heterogeneity in carrageenan oligosaccharides.

Mendis P, Sasiene Z, Ropartz D, Rogniaux H, Jackson G Anal Bioanal Chem. 2021; 414(1):303-318.

PMID: 34050776 DOI: 10.1007/s00216-021-03396-3.


N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.

Craciun I, Fenner A, Kerns R Glycobiology. 2016; 26(7):701-709.

PMID: 26850997 PMC: 4976519. DOI: 10.1093/glycob/cww011.


Oligosaccharide analysis by mass spectrometry: a review of recent developments.

Kailemia M, Ruhaak L, Lebrilla C, Jonathan Amster I Anal Chem. 2013; 86(1):196-212.

PMID: 24313268 PMC: 3924431. DOI: 10.1021/ac403969n.


Selective inhibition of bacterial and human topoisomerases by arylacyl -sulfonated aminoglycoside derivatives.

Fenner A, Oppegard L, Hiasa H, Kerns R ACS Med Chem Lett. 2013; 4(5):470-474.

PMID: 23814643 PMC: 3694624. DOI: 10.1021/ml3004507.

References
1.
Nielsen T, Rozek T, Hopwood J, Fuller M . Determination of urinary oligosaccharides by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry: Application to Hunter syndrome. Anal Biochem. 2010; 402(2):113-20. DOI: 10.1016/j.ab.2010.04.002. View

2.
Casu B, Vlodavsky I, Sanderson R . Non-anticoagulant heparins and inhibition of cancer. Pathophysiol Haemost Thromb. 2009; 36(3-4):195-203. PMC: 2768601. DOI: 10.1159/000175157. View

3.
Johnstone K, Karoli T, Liu L, Dredge K, Copeman E, Li C . Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth. J Med Chem. 2010; 53(4):1686-99. DOI: 10.1021/jm901449m. View

4.
Thanawiroon C, Rice K, Toida T, Linhardt R . Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides. J Biol Chem. 2003; 279(4):2608-15. DOI: 10.1074/jbc.M304772200. View

5.
Laremore T, Zhang F, Dordick J, Liu J, Linhardt R . Recent progress and applications in glycosaminoglycan and heparin research. Curr Opin Chem Biol. 2009; 13(5-6):633-40. PMC: 2787697. DOI: 10.1016/j.cbpa.2009.08.017. View